Alopecia Market Size and Forecast 2024-2033| Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG

Overview and Scope

Alopecia is a medical term that refers to hair loss, which can occur naturally or be related to disease or the use of certain medications. It can be localized or diffuse, temporary or permanent, and can affect both sexes and all age groups. Alopecia treatment aims to slow down, reverse, or manage hair loss and promote hair regrowth in affected areas

Sizing and Forecast

The alopecia market size has grown strongly in recent years. It will grow from $5.28 billion in 2023 to $5.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see strong growth in the next few years. It will grow to $7.82 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Segmentation & Regional Insights

The alopecia market covered in this report is segmented –

1) By Type: Alopecia Areata; Androgenetic Alopecia; Alopecia Totalis; Traction Alopecia; Cicatricial Alopecia; Other Types

2) By Treatment: Pharmaceutical; Low Level Laser Therapy (LLLT) Devices; Hair Transplant; Regenerative Medicine; Other Treatments

3) By Gender: Male; Female

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

5) By End-User: Dermatology Clinics; Homecare Settings; Other End-Users

North America was the largest region in the alopecia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12862&type=smp

Major Driver Impacting Market Growth

The increase in the prevalence of hair loss is expected to propel the growth of the alopecia market going forward. Hair loss refers to the partial or complete loss of hair from areas where it usually grows. Alopecia treatment helps alopecia patients by addressing several issues with hair loss by extending hair regrowth, creating customized treatment plans, using combination therapies, and managing the physical aspect of hair loss, as these can have significant positive effects on a person’s emotional well-being and quality of life. For instance, in April 2023, according to the data from the National Health Commission, a China-based executive department, over 250 million Chinese experienced hair loss, of which 42% were aged between 26 and 30. Furthermore, in February 2023, according to the Statistic Brain Research Institute, a US-based educational institute, approximately 40% of men will suffer from visible hair loss by age 35. Therefore, the increase in the prevalence of hair loss is driving the alopecia market.

Key Industry Players

Major players in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

The alopecia market report table of contents includes:

1. Executive Summary

2. Alopecia Market Characteristics

3. Alopecia Market Trends And Strategies

4. Alopecia Market – Macro Economic Scenario

5. Global Alopecia Market Size and Growth

26. South America Alopecia Market

27. Brazil Alopecia Market

28. Middle East Alopecia Market

29. Africa Alopecia Market

30. Alopecia Market Competitive Landscape And Company Profiles

Top Major Players: